Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis

Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):880-3.

Abstract

Venous thrombosis is a multicausal disease, more than one genetic risk factor may cooperate to effect thrombotic risk. Factor V Leiden is found to be an important hereditary risk factor for venous thromboembolism. Analogous to factor V Leiden, a point mutation at amino acid positions Arg336 and Arg562 in factor VIII may predispose patients to thrombosis. Eighty-one Thai patients with venous thrombosis and 100 Thai healthy volunteers have been studied. Neither heterozygous nor homozygous mutations were detected both thrombosis patients or normal volunteers. However, further studies with larger samples of venous thrombosis patients are recommended.

MeSH terms

  • Adult
  • Aged
  • Amino Acid Substitution
  • Arginine / genetics*
  • Base Sequence
  • Case-Control Studies
  • DNA Primers
  • Factor VIII / genetics*
  • Female
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Polymerase Chain Reaction
  • Protein C / chemistry
  • Protein C / genetics*
  • Thailand
  • Venous Thrombosis / genetics*

Substances

  • DNA Primers
  • Protein C
  • Factor VIII
  • Arginine